To the best of our knowledge, our study is the first to investigate the expression of HIF1α, VEGFA, and VEGFR2, as well as endometrial vascular features during the precisely timed implantation window in CE patients versus fertile women without CE. This evidence concerns the gene VEGFA and cholesteryl ester measurement.